A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Jamy, Omer [1 ]
Innis-Shelton, Racquel [2 ]
Bal, Susan [3 ]
Salzman, Donna [4 ,5 ]
Costa, Luciano J. [4 ,5 ]
di Stasi, Antonio [6 ]
Lamb, Lawrence [2 ]
Mineishi, Shin [7 ]
Saad, Ayman [4 ,5 ]
机构：
[1] Univ Alabama Birmingham Hosp, Birmingham, AL USA
[2] Univ Alabama Birmingham, Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Alabama Birmingham Hosp, Bone Marrow Transplantat & Cell Therapy Program, Birmingham, AL USA
[5] Univ Alabama Birmingham Hosp, Dept Med, Div Hematol Oncol, Birmingham, AL USA
[6] Univ ofAlabama, Stem Cell Transplantat & Cellular Therapy, Birmingham, AL USA
[7] Penn State Hershey Med Ctr, Blood & Marrow Transplantat Program, Hershey, PA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
280
引用
收藏
页码：S190 / S191
页数：2
相关论文
共 50 条
  • [1] A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
    Jamy, Omer
    Innis-Shelton, Racquel
    Bal, Susan
    Paluri, Ravi K.
    Karim, Samina
    Chewning, Joseph H.
    Salzman, Donna
    Costa, Luciano J.
    Di Stasi, Antonio
    Lamb, Lawrence S., Jr.
    Mineishi, Shin
    Saad, Ayman
    BLOOD, 2019, 134
  • [2] Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation
    Jamy, Omer
    Innis-Shelton, Raquel
    Bal, Susan
    Paluri, Ravi
    Salzman, Donna
    Di Stasi, Antonio
    Costa, Luciano
    Meredith, Ruby
    Lamb, Lawrence
    Minagawa, Kentaro
    Mineishi, Shin
    Saad, Ayman
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) : E396 - E398
  • [3] Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation
    Al Malki, Monzr M.
    Bo-Subait, Stephanie
    Logan, Brent
    Olson, Janelle
    Leckrone, Erin
    Wu, Juan
    Stefanski, Heather E.
    Auletta, Jeffery J.
    Spellman, Stephen R.
    Malmberg, Craig
    Shaffer, Brian C.
    Modi, Dipenkumar
    Khimani, Farhad
    Gooptu, Mahasweta
    Hamadani, Mehdi
    Broglie, Larisa
    Shaw, Bronwen E.
    Devine, Steven Michael
    Jimenez, Antonio Martin Jimenez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Efficacy of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Peripheral Blood Stem Cell HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation; A Prospective Pilot Trial
    Al Malki, Monzr M.
    Tsai, Ni-Chun
    Palmer, Joycelynne
    Mokhtari, Saloomeh
    Cao, Thai
    Ali, Haris
    Salhotra, Amandeep
    Arslan, Shukaib
    Aldoss, Ibrahim
    Karras, Nicole
    Ali, Haris M.
    Ali, Haris
    Stein, Anthony S.
    Snyder, David S.
    Marcucci, Guido
    Forman, Stephen J.
    Nakamura, Ryotaro
    BLOOD, 2020, 136
  • [5] A Phase II Trial of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation
    Al Malki, Monzr M.
    Tsai, Ni-Chun
    Palmer, Joycelynne
    Mokhtari, Sally
    Cao, Thai
    Ali, Haris
    Salhotra, Amandeep
    Arslan, Shukaib
    Aldoss, Ibrahim
    Karras, Nicole
    Zain, Jasmine
    Khaled, Samer K.
    Stein, Anthony S.
    Snyder, David S.
    Marcucci, Guido
    Forman, Stephen J.
    Nademanee, Auayporn
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S188 - S188
  • [6] Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
    Kunacheewa, Chutima
    Owattanapanish, Weerapat
    Jirabanditsakul, Chutirat
    Issaragrisil, Surapol
    CELL TRANSPLANTATION, 2020, 29
  • [7] Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation
    Miekarek, Marco
    Furlong, Terry
    O'Donnell, Paul V.
    Storer, Barry E.
    McCune, Jeannine S.
    Storb, Rainer F.
    Carpenter, Paul A.
    Flowers, Mary E. D.
    Appelbaum, Frederick R.
    Martin, Paul J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S406 - S406
  • [8] Comparison of pre-transplant thymoglobulin and post-transplant prednisolone as graft-versus-host disease prophylaxis in matched unrelated donor, peripheral blood stem cell transplantation
    Ritchie, D. S.
    Lim, A.
    Li, E.
    Mason, K.
    Hoyt, R.
    He, S.
    Bajel, A.
    Roberts, A. W.
    Grigg, A. P.
    Szer, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S152 - S152
  • [9] Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience
    Innis-Shelton, Racquel
    Salzman, Donna
    Di Stasi, Antonio
    Lamb, Lawrence S.
    Gazi, Melissa
    Williams, Lisa
    Costa, Luciano J.
    Erba, Harry
    Mineishi, Shin
    Saad, Ayman
    BLOOD, 2014, 124 (21)
  • [10] Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation
    Mielcarek, Marco
    Furlong, Terrence
    O'Donnell, Paul V.
    Storer, Barry E.
    Storb, Rainer F.
    Carpenter, Paul A.
    Martin, Paul J.
    BLOOD, 2014, 124 (21)
12345